Allergy Diagnostics

Global Allergy Diagnostics Market to Reach US$8.3 Billion by 2030

The global market for Allergy Diagnostics estimated at US$4.7 Billion in the year 2024, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$4.5 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 9.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 14.5% CAGR

The Allergy Diagnostics market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 14.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 9.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Global Allergy Diagnostics Market - Key Trends & Drivers Summarized

Allergy diagnostics encompasses a range of tests and procedures used to identify allergic reactions and pinpoint specific allergens responsible for these reactions. Allergies occur when the immune system reacts to foreign substances, such as pollen, food, or pet dander, which are typically harmless to most people. The primary methods of allergy diagnostics include skin tests, blood tests, and challenge tests. Skin tests, such as prick tests or intradermal tests, involve exposing the skin to potential allergens and observing the reaction. Blood tests, like the radioallergosorbent test (RAST) and enzyme-linked immunosorbent assay (ELISA), measure the presence of specific antibodies (IgE) that the immune system produces in response to allergens. Challenge tests are conducted under medical supervision and involve introducing small amounts of allergens to the patient and monitoring for adverse reactions. These diagnostic tools are crucial for accurately diagnosing allergies and devising appropriate management and treatment plans.

Technological advancements have significantly improved the accuracy, efficiency, and convenience of allergy diagnostics. Modern diagnostic techniques leverage advanced immunoassays and molecular diagnostics to detect specific allergen components, offering a more detailed understanding of allergic sensitivities. Multiplex testing platforms allow for the simultaneous analysis of multiple allergens from a single blood sample, enhancing the comprehensiveness of diagnostic evaluations. Furthermore, innovations in point-of-care testing enable rapid and on-site allergy assessments, providing immediate results and facilitating timely clinical decisions. These advancements are particularly beneficial in pediatric allergy diagnostics, where non-invasive and quick procedures are preferred. The integration of digital health tools, such as electronic health records (EHRs) and mobile health applications also supports allergy diagnostics by streamlining data management, improving patient monitoring, and enhancing communication between patients and healthcare providers.

The growth in the allergy diagnostics market is driven by several factors, including the increasing prevalence of allergic diseases, rising awareness about allergy management, and advancements in diagnostic technologies. The global burden of allergic conditions, such as asthma, allergic rhinitis, and food allergies, is on the rise, necessitating effective diagnostic solutions to manage and treat these conditions. Growing public awareness and education about allergies have led to higher demand for diagnostic testing, as more individuals seek to identify and manage their allergic triggers. Technological innovations have made allergy diagnostics more accessible and accurate, encouraging healthcare providers to adopt these advanced tools in clinical practice. Additionally, supportive government initiatives and healthcare policies aimed at improving allergy care and management are bolstering market growth. The expansion of healthcare infrastructure and increased investment in research and development further contribute to the market`s positive trajectory. As these trends continue, the allergy diagnostics market is poised for significant growth, driven by the ongoing need for precise, efficient, and patient-centric diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Allergy Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Assay Kits, Instruments, Services); Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens); End-Use (Hospitals, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 100 Featured) -

• 3M Company
• Bausch & Lomb, Inc.
• ACON Laboratories, Inc.
• Awareness Technology, Inc.
• ALK-Abello A/S
• Allergy Therapeutics Plc
• Alpha Laboratories Ltd.
• Angsana Molecular & Diagnostics Laboratory Pte Ltd.
• Bausch Health Companies Inc.
• Alkor Bio Group
• ALLERGOPHARMA GmbH & Co. KG
• AESKU.Diagnostics GmbH & Co. KG
• AllerGenis, Inc.
• Astra Biotech GmbH
• Assure Tech. (Hangzhou) Co., Ltd

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.